Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

被引：9
|
作者：
Lazaro-Navarro, Juan [1 ,2 ]
Pimentel-Gutierrez, Helia Judith [1 ,2 ]
Gauert, Anton [1 ,2 ]
Hagemann, Anja I. H. [1 ]
Eisenschmid, Jassi [3 ,4 ]
Goekbuget, Nicola [2 ,4 ]
Vick, Binje [2 ,5 ]
Jeremias, Irmela [2 ,5 ]
Seyfried, Felix [6 ]
Meyer, Luder Hinrich [6 ]
Debatin, Klaus-Michael [6 ]
Richer, Kathrin [7 ]
Bultman, Miriam [7 ]
Neumann, Martin [2 ,7 ]
Hanzelmann, Sonja [2 ]
Serve, Hubert [2 ,3 ,4 ]
Astrahantseff, Kathy [1 ]
Rieger, Michael A. [2 ,3 ,4 ]
Eckert, Cornelia [1 ,2 ]
Baldus, Claudia D. [2 ,7 ]
Bastian, Lorenz [2 ,7 ]
机构：
[1] Charit Univ med Berlin, Dept Pediat Oncol Hematol, Berlin, Germany
[2] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[3] Frankfurt Canc Inst, Frankfurt, Germany
[4] Goethe Univ Hosp Frankfurt, Dept Med Hematol Oncol, Frankfurt, Germany
[5] Helmholtz Ctr Munich German Ctr Environm Hlth HMG, Dept Apoptosis Hematopoiet Stem Cells, Munich, Germany
[6] Univ Ulm, Dept Pediat & Adolescent Med, Med Ctr, Ulm, Germany
[7] Univ Med Ctr Schleswig Holstein, Med Dept 2, Hematol Oncol, Campus Kiel, Kiel, Germany
来源：
BLOOD ADVANCES | 2021年 / 5卷 / 24期
关键词：
BCL-2; DEPENDENCE; APOPTOSIS; CK2; ACTIVATION; GENOMICS;
D O I：
10.1182/bloodadvances.2021004513
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5501 / 5506
页数：6
相关论文
共 50 条
  • [41] Wnt/β-Catenin Inhibitor Combined with Venetoclax Synergistically Induce Apoptosis in Acute Myeloid Leukemia By Increasing the Degradation of MCL-1 Protein
    Pan, Mengya
    Sun, Menghua
    Zhou, Junjie
    Jiao, Changqing
    Chen, Enbo
    Wu, Zhonghui
    Ma, Xiaoyu
    Liu, Xiaoying
    Ge, Jian
    BLOOD, 2024, 144 : 5779 - 5780
  • [42] Hypomethylating Agents and Casein Kinase 2 Inhibitor Act Synergistic and Reveal Significant Anti-Leukemic Effects in Acute Lymphoblastic Leukemia Cells
    Roolf, Catrin
    Richter, Anna
    Konkolefski, Christoph
    Khodamoradi, Yascha
    Knuebel, Gudrun
    Sekora, Anett
    Stenzel, Jan
    Krause, Bernd Joachim
    Vollmar, Brigitte
    Jeremias, Irmela
    Panse, Jens P.
    Escobar, Hugo Murua
    Junghanss, Christian
    BLOOD, 2016, 128 (22)
  • [43] Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway
    Zhou, Vivian
    Bachelor, Luke Moat
    Yu, Manya
    Parashar, Deepak
    Shour, Abdul
    Zhang, Liang
    Kitchner, Terrie
    Shukla, Sanjay
    Guo, Song
    Ananiev, Gene
    Katzenellenbogen, Benita S.
    Katzenellenbogen, John
    Onitilo, Adedayo
    Janz, Siegfried
    Wen, Zhi
    BLOOD, 2023, 142
  • [44] Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
    Fidyt, Klaudyna
    Pastorczak, Agata
    Cyran, Julia
    Crump, Nicholas T.
    Goral, Agnieszka
    Madzio, Joanna
    Muchowicz, Angelika
    Poprzeczko, Martyna
    Domka, Krzysztof
    Komorowski, Lukasz
    Winiarska, Magdalena
    Harman, Joe R.
    Siudakowska, Karolina
    Graczyk-Jarzynka, Agnieszka
    Patkowska, Elzbieta
    Lech-Maranda, Ewa
    Mlynarski, Wojciech
    Golab, Jakub
    Milne, Thomas A.
    Firczuk, Malgorzata
    ONCOGENE, 2022, 41 (11) : 1600 - 1609
  • [45] Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
    Klaudyna Fidyt
    Agata Pastorczak
    Julia Cyran
    Nicholas T. Crump
    Agnieszka Goral
    Joanna Madzio
    Angelika Muchowicz
    Martyna Poprzeczko
    Krzysztof Domka
    Lukasz Komorowski
    Magdalena Winiarska
    Joe R. Harman
    Karolina Siudakowska
    Agnieszka Graczyk-Jarzynka
    Elzbieta Patkowska
    Ewa Lech-Maranda
    Wojciech Mlynarski
    Jakub Golab
    Thomas A. Milne
    Malgorzata Firczuk
    Oncogene, 2022, 41 : 1600 - 1609
  • [46] Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia
    Askarian-Amiri, Shaghayegh
    Aval, Farzane Ordoni
    Azadmehr, Abbas
    Oladnabi, Morteza
    Vesiehsari, Mahjoobeh Jafari
    Hajiahmadi, Mahmoud
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (04)
  • [47] Synergistic Interaction between the MCL-1-Specific Inhibitor S63845 and Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia
    Seyfried, Felix
    Stirnweiss, Felix
    Koehrer, Stefan
    Debatin, Klaus-Michael
    Meyer, Lueder Hinrich
    CELL DEATH DISCOVERY, 2019, 5
  • [48] p16INK4A Sensitizes Human Leukemia Cells to FAS- and Glucocorticoid-induced Apoptosis via Induction of BBC3/Puma and Repression of MCL1 and BCL2
    Obexer, Petra
    Hagenbuchner, Judith
    Rupp, Martina
    Salvador, Christina
    Holzner, Markus
    Deutsch, Martin
    Porto, Verena
    Kofler, Reinhard
    Unterkircher, Thomas
    Ausserlechner, Michael J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (45) : 30933 - 30940
  • [49] ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression
    Qi, Leilei
    Zhang, Baotong
    Zhang, Shiying
    Ci, Xinpei
    Wu, Qiao
    Ma, Gui
    Luo, Ang
    Fu, Liya
    King, Jamie L.
    Nahta, Rita
    Dong, Jin-Tang
    ONCOTARGET, 2017, 8 (22) : 36054 - 36066
  • [50] The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
    Zhaodong Li
    Shuning He
    A. Thomas Look
    Leukemia, 2019, 33 : 262 - 266
12345